In primary sclerosing cholangitis, gallbladder polyps are frequently malignant

Daniel C. Buckles, Keith D. Lindor, Nicholas F La Russo, Lydia M. Petrovic, Gregory James Gores

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

OBJECTIVE: The management of gallbladder polyps/masses in patients with primary sclerosing cholangitis (PSC) (i.e., cholecystectomy vs observation) remains problematic. Given the risk of biliary tract cancer in PSC in the face of the benign nature of most gallbladder polyps in the general population, our aim was to determine the prevalence of gallbladder cancer in PSC patients with a gallbladder mass who had undergone cholecystectomy. METHODS: The case records of all patients with PSC undergoing a cholecystectomy at the Mayo Clinic between 1977-1999 were reviewed. RESULTS: Of the 102 patients with PSC who underwent a cholecystectomy, 14 of 102 (13.7%) had a gallbladder mass. In the subset of patients with gallbladder masses, eight of 14 (57%) had adenocarcinomas (seven primary adenocarcinomas and one metastatic cholangiocarcinoma); the other six had benign masses (five adenomas and one cholesterol polyp). In those patients with benign masses, 33% had associated epithelial cell dysplasia; in patients with primary gallbladder cancers, 57% had associated dysplasia. The patients with primary gallbladder adenocarcinoma had a favorable outcome after cholecystectomy, with a 36-month survival of 66%. CONCLUSIONS: In conclusion, gallbladder neoplasms in PSC patients are malignant in approximately 40-60% of the cases. The presence of gallbladder epithelial cell dysplasia suggests a dysplasia-carcinoma sequence in PSC similar to that observed in ulcerative colitis. Consideration should be given to performing a cholecystectomy in PSC patients with gallbladder polyps. If a cholecystectomy is not performed, careful interval follow-up is warranted.

Original languageEnglish (US)
Pages (from-to)1138-1142
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume97
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Sclerosing Cholangitis
Polyps
Gallbladder
Cholecystectomy
Gallbladder Neoplasms
Adenocarcinoma
Epithelial Cells
Biliary Tract Neoplasms
Cholangiocarcinoma
Ulcerative Colitis
Adenoma
Cholesterol
Observation
Carcinoma

ASJC Scopus subject areas

  • Gastroenterology

Cite this

In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. / Buckles, Daniel C.; Lindor, Keith D.; La Russo, Nicholas F; Petrovic, Lydia M.; Gores, Gregory James.

In: American Journal of Gastroenterology, Vol. 97, No. 5, 2002, p. 1138-1142.

Research output: Contribution to journalArticle

Buckles, Daniel C. ; Lindor, Keith D. ; La Russo, Nicholas F ; Petrovic, Lydia M. ; Gores, Gregory James. / In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. In: American Journal of Gastroenterology. 2002 ; Vol. 97, No. 5. pp. 1138-1142.
@article{0bbd124ef17b440cb2ff80b1b08d6632,
title = "In primary sclerosing cholangitis, gallbladder polyps are frequently malignant",
abstract = "OBJECTIVE: The management of gallbladder polyps/masses in patients with primary sclerosing cholangitis (PSC) (i.e., cholecystectomy vs observation) remains problematic. Given the risk of biliary tract cancer in PSC in the face of the benign nature of most gallbladder polyps in the general population, our aim was to determine the prevalence of gallbladder cancer in PSC patients with a gallbladder mass who had undergone cholecystectomy. METHODS: The case records of all patients with PSC undergoing a cholecystectomy at the Mayo Clinic between 1977-1999 were reviewed. RESULTS: Of the 102 patients with PSC who underwent a cholecystectomy, 14 of 102 (13.7{\%}) had a gallbladder mass. In the subset of patients with gallbladder masses, eight of 14 (57{\%}) had adenocarcinomas (seven primary adenocarcinomas and one metastatic cholangiocarcinoma); the other six had benign masses (five adenomas and one cholesterol polyp). In those patients with benign masses, 33{\%} had associated epithelial cell dysplasia; in patients with primary gallbladder cancers, 57{\%} had associated dysplasia. The patients with primary gallbladder adenocarcinoma had a favorable outcome after cholecystectomy, with a 36-month survival of 66{\%}. CONCLUSIONS: In conclusion, gallbladder neoplasms in PSC patients are malignant in approximately 40-60{\%} of the cases. The presence of gallbladder epithelial cell dysplasia suggests a dysplasia-carcinoma sequence in PSC similar to that observed in ulcerative colitis. Consideration should be given to performing a cholecystectomy in PSC patients with gallbladder polyps. If a cholecystectomy is not performed, careful interval follow-up is warranted.",
author = "Buckles, {Daniel C.} and Lindor, {Keith D.} and {La Russo}, {Nicholas F} and Petrovic, {Lydia M.} and Gores, {Gregory James}",
year = "2002",
doi = "10.1016/S0002-9270(02)04033-9",
language = "English (US)",
volume = "97",
pages = "1138--1142",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - In primary sclerosing cholangitis, gallbladder polyps are frequently malignant

AU - Buckles, Daniel C.

AU - Lindor, Keith D.

AU - La Russo, Nicholas F

AU - Petrovic, Lydia M.

AU - Gores, Gregory James

PY - 2002

Y1 - 2002

N2 - OBJECTIVE: The management of gallbladder polyps/masses in patients with primary sclerosing cholangitis (PSC) (i.e., cholecystectomy vs observation) remains problematic. Given the risk of biliary tract cancer in PSC in the face of the benign nature of most gallbladder polyps in the general population, our aim was to determine the prevalence of gallbladder cancer in PSC patients with a gallbladder mass who had undergone cholecystectomy. METHODS: The case records of all patients with PSC undergoing a cholecystectomy at the Mayo Clinic between 1977-1999 were reviewed. RESULTS: Of the 102 patients with PSC who underwent a cholecystectomy, 14 of 102 (13.7%) had a gallbladder mass. In the subset of patients with gallbladder masses, eight of 14 (57%) had adenocarcinomas (seven primary adenocarcinomas and one metastatic cholangiocarcinoma); the other six had benign masses (five adenomas and one cholesterol polyp). In those patients with benign masses, 33% had associated epithelial cell dysplasia; in patients with primary gallbladder cancers, 57% had associated dysplasia. The patients with primary gallbladder adenocarcinoma had a favorable outcome after cholecystectomy, with a 36-month survival of 66%. CONCLUSIONS: In conclusion, gallbladder neoplasms in PSC patients are malignant in approximately 40-60% of the cases. The presence of gallbladder epithelial cell dysplasia suggests a dysplasia-carcinoma sequence in PSC similar to that observed in ulcerative colitis. Consideration should be given to performing a cholecystectomy in PSC patients with gallbladder polyps. If a cholecystectomy is not performed, careful interval follow-up is warranted.

AB - OBJECTIVE: The management of gallbladder polyps/masses in patients with primary sclerosing cholangitis (PSC) (i.e., cholecystectomy vs observation) remains problematic. Given the risk of biliary tract cancer in PSC in the face of the benign nature of most gallbladder polyps in the general population, our aim was to determine the prevalence of gallbladder cancer in PSC patients with a gallbladder mass who had undergone cholecystectomy. METHODS: The case records of all patients with PSC undergoing a cholecystectomy at the Mayo Clinic between 1977-1999 were reviewed. RESULTS: Of the 102 patients with PSC who underwent a cholecystectomy, 14 of 102 (13.7%) had a gallbladder mass. In the subset of patients with gallbladder masses, eight of 14 (57%) had adenocarcinomas (seven primary adenocarcinomas and one metastatic cholangiocarcinoma); the other six had benign masses (five adenomas and one cholesterol polyp). In those patients with benign masses, 33% had associated epithelial cell dysplasia; in patients with primary gallbladder cancers, 57% had associated dysplasia. The patients with primary gallbladder adenocarcinoma had a favorable outcome after cholecystectomy, with a 36-month survival of 66%. CONCLUSIONS: In conclusion, gallbladder neoplasms in PSC patients are malignant in approximately 40-60% of the cases. The presence of gallbladder epithelial cell dysplasia suggests a dysplasia-carcinoma sequence in PSC similar to that observed in ulcerative colitis. Consideration should be given to performing a cholecystectomy in PSC patients with gallbladder polyps. If a cholecystectomy is not performed, careful interval follow-up is warranted.

UR - http://www.scopus.com/inward/record.url?scp=0036245201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036245201&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(02)04033-9

DO - 10.1016/S0002-9270(02)04033-9

M3 - Article

C2 - 12014717

AN - SCOPUS:0036245201

VL - 97

SP - 1138

EP - 1142

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 5

ER -